ULBI trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ULBI achieves its forward estimates and maintains a stable P/E multiple of 7.0x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Ultralife Corporation (ULBI) has a Wall Street consensus price target of N/A, based on estimates from 2 covering analysts. The company has a market capitalization of $100M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ULBI trades at a trailing P/E of -17.1x and forward P/E of 7.0x. Analysts expect EPS to grow +274.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
FLUXFlux Power Holdings, Inc. | $13M | $0.75 | — | — | — | — | — |
CBATCBAK Energy Technology, Inc. | $44M | $0.50 | — | — | — | — | — |
MVSTMicrovast Holdings, Inc. | $356M | $1.07 | $4.80 | +348.6% | Buy | 9.7x | 6 |
CLFDClearfield, Inc. | $445M | $32.49 | $44.00 | +35.4% | Buy | 61.6x | 9 |
LIQTLiqTech International, Inc. | $7M | $0.75 | — | — | — | — | — |
BWENBroadwind, Inc. | $97M | $4.16 | $3.50 | -15.9% | Buy | — | 7 |
ENREnergizer Holdings, Inc. | $1.4B | $20.69 | $23.00 | +11.2% | Hold | 5.9x | 24 |
DRSLeonardo DRS, Inc. | $12.1B | $45.47 | $53.33 | +17.3% | Buy | 35.2x | 9 |
KTOSKratos Defense & Security Solutions, Inc. | $9.4B | $50.34 | $107.92 | +114.4% | Buy | 65.8x | 24 |
AMKRAmkor Technology, Inc. | $16.2B | $65.33 | $76.00 | +16.3% | Hold | 31.4x | 14 |
Quick answers to the most common questions about buying ULBI stock.
The consensus price target for ULBI is $N/A, close to the current price of $5.98 (N/A% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.
ULBI has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 6.9535x, ULBI trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for ULBI, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
ULBI is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ULBI stock forecast based on 2 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
ULBI trades at a forward P/E ratio of 7.0x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
ULBI appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ULBI analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.